Emcure to launch generic breast cancer medicine

Eribulin, sold by Japanese drug maker Eisai under brand name Halaven, is used to treat HER 2 negative patients. It costs Rs 5,000 per vial.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2HVXV6I
via IFTTT